Understanding and overcoming metformin gastrointestinal intolerance
Dec 11 2016 André Scheen MD
Effect of sodium-glucose cotransporter type 2 inhibitors on liver fat in
Correspondence to: Professor André J. Scheen. Department of Medicine CHU Sart Tilman (B35)
Personalising metformin therapy : a clinician perspective
Professor André J. SCHEEN. Department of Medicine. CHU Sart Tilman (B35) Email : andre.scheen@chu.ulg.ac.be. Metformin is the first-line pharmacological ...
Once-weekly DPP-4 inhibitors: do they meet an unmet need?
Professor André J. SCHEEN. Department of Medicine. CHU Sart Tilman (B35) Email : andre.scheen@chu.ulg.ac.be. Dipeptidyl peptidase (DPP-4) inhibitors ...
Sibutramine : review of its cardiovascular risk-benefit profile
A.J. SCHEEN. University of Liège Division of Diabetes Professor André J. SCHEEN. Department of Medicine ... Email : andre.scheen@chu.ulg.ac.be. SUMMARY.
DIABETES & METABOLISM
Professor Atlanta
New injection recommendations for patients with diabetes
Louis Monnier (Montpellier) André Scheen (Liège)
Combatting the dual burden: therapeutic targeting of common
André J. Scheen1 and Luc F. Van Gaal 2. SHORT TITLE Correspondence to: Professor Scheen AJ Division of Diabetes
Untitled
Belgium. E-mail: Andre.Scheen@chu.ulg.ac.be. Keywords insulin resistance; thiazolidinediones; type 2 diabetes; rosiglita- zone; pioglitazone; troglitazone.
ASSEMBLEE GENERALE SOCIETE FRANCOPHONE DU DIABETE
Mar 12 2014 Le Président de la SFD
